Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-4
Closed -$141K – 754
2017
Q2
$141K Hold
4
– – ﹤0.01% 698
2017
Q1
$157K Hold
4
– – ﹤0.01% 684
2016
Q4
$176K Hold
4
– – ﹤0.01% 661
2016
Q3
$52K Hold
4
– – ﹤0.01% 655
2016
Q2
$53K Hold
4
– – ﹤0.01% 653
2016
Q1
$429K Hold
4
– – 0.01% 569
2015
Q4
$459K Buy
4
+1
+33% +$115K 0.01% 471
2015
Q3
$410K Hold
3
– – 0.01% 551
2015
Q2
$527K Hold
3
– – 0.01% 529
2015
Q1
$621K Buy
3
+2
+200% +$437K 0.01% 520
2014
Q4
$199K Buy
+1
New +$151K ﹤0.01% 614

Other funds holding NVCN

Candriam SCA's NVCN Position: Q3 2017 in Review

Candriam SCA sold out of Neovasc (NVCN) in Q3 2017, closing a stake of 4 shares — an estimated $141K sold.

Candriam SCA first reported a position in NVCN in Q4 2014 and held it in 11 quarters. The position peaked at $621K in Q1 2015. 10 funds tracked by Wall St. Rank hold NVCN as of Q3 2017.

  • Candriam SCA reported no remaining Neovasc position as of Q3 2017 after selling out during the quarter.
  • Candriam SCA sold 4 Neovasc shares in Q3 2017, an estimated $141K.
  • Candriam SCA first reported a position in Neovasc in Q4 2014 and held it in 11 quarters.
  • Candriam SCA's Neovasc position peaked at $621K in Q1 2015.
  • 10 funds tracked by Wall St. Rank held Neovasc as of Q3 2017.

Based on Candriam SCA's 13F filing for Q3 2017, filed 3 Nov 2017.